Please login to the form below

Not currently logged in
Email:
Password:

autoimmune disease

This page shows the latest autoimmune disease news and features for those working in and with pharma, biotech and healthcare.

GSK’s Benlysta given orphan drug status by FDA for systemic sclerosis

GSK’s Benlysta given orphan drug status by FDA for systemic sclerosis

The rare autoimmune disease affects two to ten people per million and has limited treatments. ... Affecting two to ten people per million, SSc is a rare autoimmune disease that causes unusual growth of connective tissues and can affect a patient’s

Latest news

More from news
Approximately 13 fully matching, plus 98 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest appointments

  • New hires at Nanoform, Leo Pharma and Calliditas New hires at Nanoform, Leo Pharma and Calliditas

    IgA nephropathy (IgAN) – also known as Berger’s disease. ... Currently, there are no approved treatments for IgA Nephropathy, and Nefecon has the potential to be a disease-modifying treatment for patients suffering from this chronic autoimmune disease

  • Akari Therapeutics strengthens board Akari Therapeutics strengthens board

    His expertise has seen him led transactions across a broad span of deal-types, geographies, and therapeutic disease areas and he brings experience in business and corporate development, finance, marketing and ... As Akari continues its mission to develop

  • David Horn Solomon takes the helm of Akari Therapeutics David Horn Solomon takes the helm of Akari Therapeutics

    biopharma as it focuses on the development and commercialisation of orphan autoimmune and inflammatory disease treatments.

  • Caldan Therapeutics appoints CEO Caldan Therapeutics appoints CEO

    Dr Payton joins the metabolic disease specialist - a spin-out company from the Universities of Glasgow and Southern Denmark - from MAPBiotech, where he has served as chief executive officer since 2014. ... He co-founded autoimmune disease-focused Orca

  • Santhera CEO Klaus Schollmeier joins SuppreMol Santhera CEO Klaus Schollmeier joins SuppreMol

    In his new position at autoimmune disease specialists SuppreMol, Schollmeier succeeds Professor Peter Buckell who retires. ... He said: "The company has a very promising product candidate for the treatment of autoimmune diseases in phase II clinical

More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

  • What does the future hold for clinical trial recruitment?

    For example, new commonalities have been discovered between Type 1 diabetes, lupus, multiple sclerosis and rheumatoid arthritis, suggesting that drugs already in use to treat one autoimmune disease could be equally

  • RP Investigates - Q&A session: Living with Lupus

    This session is a perfect opportunity to listen first-hand to a patient suffering with this debilitating autoimmune disease and find out how pharma can help.

  • Lupus Awareness Month Lupus Awareness Month

    Lupus is an autoimmune disease as it causes the immune system to attack healthy cells in the body.

  • The other side of … Crohn’s disease

    The other side of … Crohn’s disease. “After visiting about seven doctors in two different countries, I am confident to say that all can align on 2–3 points at most”. ... Meet Irene. Like millions of others worldwide (and an estimated  115, 000

  • PANDAS/PANS Awareness: A parent’s story

    parent of a son recently diagnosed with PANDAS (paediatric autoimmune neuropsychiatric disorder associated with Streptococcus)…. ... As PANDAS is an autoimmune disease that leads to inflammation in the basal ganglia region of the brain, the symptoms

More from PMHub
Approximately 1 fully matching, plus 11 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Springer Nature

Operating in 50+ countries, we’re a leading research, educational, and professional publisher dedicated to advancing scientific discovery. Whether you’re looking...

Latest intelligence

World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
Strategic behaviour
Strong strategising depends on your colleagues’ behaviour...
Pharmaceutical Marketing Strategies For The Digital Age
In the digital age, a strong digital marketing strategy is crucial for businesses, especially in the highly competitive and complex pharmaceutical industry. There are key trends shaping pharmaceutical marketing, such...